We will continue clinical analgesic assays and pharmacokinetic studies to determine whether 1, Alpha-acetylmethadol (LAAM), a drug biotransformed to active metabolites, has any advantages over conventional narcotics in the management of pain due to cancer. We will develop a pharmacokinetic model for LAAM in maintenance patients to assist in the individualization of dosing during induction and complete pharmacologic and pharmacokinetic studies in the rat. This proposal has two new main objectives. The first is to develop a novel method for the simultaneous quantitation of the precursors and products of endorphin, enkephalin and dynorphin biosynthesis. This method will be applied to studies of the effects of opioid agonist and antagonist drugs on opioid peptide biosynthesis in the selected CNS tissues (striatum, hippocampus, hypothalamus, anterior and intermediate-posterior lobe) of rats and guinea pigs. The dosing schedules to be used are based on our pharmacokinetic studies and will allow sustained plasma drug levels during treatment and produce tolerance and physical dependence. These studies will provide the first comprehensive assessment of the effects of chronic treatment with opiate agonist and antagonist drugs on the biosynthesis of each of the three opioid peptide families. The time-course of appearance and disappearance of changes in CNS opioid peptides in tolerant/dependent animals should have important implications for drug abuse and pain research. The second main objective is to examine the biosynthesis and release of adrenal enkephalin peptides and the levels of proenkephalin-mRNA in four species exposed to opiates or stressors. In these studies we will examine the influence of these treatments on enkephalin peptides and mRNA in unilaterally denervated animals. In this way we can define the role of neuroregulation on enkephalin biosynthesis and identify the site(s) where opiates and/or stressors may act to modify adrenal enkephalin peptide biosynthesis and release. These studies may provide important new information on the role of adrenal enkephalins in stress-analgesia. This researach will require high performance liquid chromatographic and radioimmunoassay methods.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA001457-10
Application #
3206917
Study Section
(SRC)
Project Start
1976-05-01
Project End
1989-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
10
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Xu, Jin; Xu, Ming; Brown, Taylor et al. (2013) Stabilization of the ?-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. J Biol Chem 288:21211-27
Hunter, Deirtra A; Barr, Gordon A; Amador, Nicole et al. (2011) Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation. Synapse 65:643-51
Hunter, Deirtra A; Barr, Gordon A; Shivers, Kai-Yvonne et al. (2011) Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia. Brain Res 1382:181-8
Schierberl, Kathryn; Hao, Jin; Tropea, Thomas F et al. (2011) Cav1.2 L-type Ca²? channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. J Neurosci 31:13562-75
Gregus, Ann M; Tropea, Thomas F; Wang, Yanran et al. (2010) Deletion of the GluR5 subunit of kainate receptors affects cocaine sensitivity and preference. Neurosci Lett 468:186-9
Weyerbacher, Amanda R; Xu, Qinghao; Tamasdan, Cristina et al. (2010) N-Methyl-D-aspartate receptor (NMDAR) independent maintenance of inflammatory pain. Pain 148:237-46
Gregus, A M; Inra, C N; Giordano 3rd, T P et al. (2010) Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5. Neuroscience 169:475-87
Bogulavsky, Johanna J; Gregus, Ann M; Kim, Paul T-H et al. (2009) Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance. J Pharmacol Exp Ther 328:579-87
Garraway, Sandra M; Xu, Qinghao; Inturrisi, Charles E (2009) siRNA-mediated knockdown of the NR1 subunit gene of the NMDA receptor attenuates formalin-induced pain behaviors in adult rats. J Pain 10:380-90
Klein, Gad; Rossi, Grace C; Waxman, Amanda R et al. (2009) The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence. Neurosci Lett 457:115-9

Showing the most recent 10 out of 52 publications